{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:49:59Z","timestamp":1791661799606,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pathol.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:18:10Z","timestamp":1788970690000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMARCB1-deficient peripheral T-cell lymphoma in a 17-year-old male: an emerging entity which expands the spectrum of SMARCB1-deficient tumours"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4735-5522","authenticated-orcid":false,"given":"Laura Ling Ying","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl Chen Lung","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8477-3670","authenticated-orcid":false,"given":"Andy Sing Ong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian Meng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siong Leng","family":"Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Wah","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Leong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2026.07.009_bib1","article-title":"Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1","volume":"4","author":"Kinnaman","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.pathol.2026.07.009_bib2","first-page":"2849","article-title":"An aggressive hematolymphoid neoplasm with homozygous SMARCB1 loss shows response to EZH2 inhibition","volume":"110","author":"Sarami","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2026.07.009_bib3","article-title":"Malignant high-grade INI1-deficient hematolymphoid neoplasm: a series of three cases","volume":"26","author":"Havens","year":"2023","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.pathol.2026.07.009_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cancergencyto.2009.03.001","article-title":"Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition","volume":"192","author":"Bug","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.pathol.2026.07.009_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","article-title":"Peripheral T cell lymphomas: from the bench to the clinic","volume":"20","author":"Fiore","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2026.07.009_bib6","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1038\/s41467-024-52826-0","article-title":"Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas","volume":"15","author":"Fischer","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2026.07.009_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/blood.2023021106","article-title":"A novel case of peripheral T-cell lymphoma, not otherwise specified, with rhabdoid morphology and INI1 loss","volume":"142","author":"Saksena","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.07.009_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.inat.2019.01.014","article-title":"Case report: the unusual case of a sellar\/suprasellar extrarenal rhabdoid tumour in an adult","volume":"17","author":"Ahmad","year":"2019","journal-title":"Interdiscip Neurosurg"},{"key":"10.1016\/j.pathol.2026.07.009_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.prp.2008.02.008","article-title":"Cytokeratin expression in hematological neoplasms: a tissue microarray study on 866 lymphoma and leukemia cases","volume":"204","author":"Adams","year":"2008","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.pathol.2026.07.009_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.24294","article-title":"Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: an analysis of 51 individuals in a single-center experience","volume":"43","author":"Piotrowski","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pathol.2026.07.009_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/gcc.22128","article-title":"SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on both mRNA and protein levels","volume":"53","author":"Papp","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2026.07.009_bib12","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41379-022-01148-x","article-title":"The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms","volume":"35","author":"Dermawan","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.07.009_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41379-019-0273-1","article-title":"Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases","volume":"32","author":"Jia","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.07.009_bib14","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1172\/JCI37210","article-title":"TCR-dependent transformation of mature memory phenotype T cells in mice","volume":"121","author":"Wang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pathol.2026.07.009_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107660","article-title":"An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid\/rhabdoid tumors (AT\/RT)","volume":"213","author":"Pauck","year":"2025","journal-title":"Pharmacol Res"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526006392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526006392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:25:35Z","timestamp":1791660335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302526006392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":15,"alternative-id":["S0031302526006392"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2026.07.009","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMARCB1-deficient peripheral T-cell lymphoma in a 17-year-old male: an emerging entity which expands the spectrum of SMARCB1-deficient tumours","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}